Purpose/Objective:
Predicting the pathological response of lymph nodes (LNs) after neoadjuvant chemoradiotherapy (NCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC) remains a significant clinical challenge. This
study aims to develop a radiomics-based model to predict the major pathological response (MPR) of LNs.
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
大类|2 区医学
小类|2 区肿瘤学2 区核医学
最新[2025]版：
大类|2 区医学
小类|2 区肿瘤学2 区核医学
JCR分区：
出版当年[2024]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版：
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构：[1]Radiation Oncology, Sichuan Cancer Hospital, Chengdu, China. [2]Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital, Chengdu, China
推荐引用方式(GB/T 7714)：
Wang Qifeng,Liu Ying,Wu Lei.Radiomics-based Prediction of Lymph Node Regression after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma[J].RADIOTHERAPY AND ONCOLOGY.2025,206:S1739-S1741.
APA：
Wang, Qifeng,Liu, Ying&Wu, Lei.(2025).Radiomics-based Prediction of Lymph Node Regression after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.RADIOTHERAPY AND ONCOLOGY,206,
MLA：
Wang, Qifeng,et al."Radiomics-based Prediction of Lymph Node Regression after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma".RADIOTHERAPY AND ONCOLOGY 206.(2025):S1739-S1741
医学